Trial of Hoya SYNC III Design Lenses
Launched by THE INSTITUTE OF OPTOMETRY, LONDON · Feb 4, 2019
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
Background Aims
The aims of the research are to use a parallel group randomised controlled trial to:
1. Evaluate whether binocular vision and accommodative functions at baseline can predict any participants who benefit from SYNC III design lenses;
2. Evaluate whether the wearing of SYNC III design lenses is associated with any changes in binocular and accommodative functions at 6 months of follow-up;
3. Evaluate whether the wearing of lenses with accommodative support may reduce the symptoms of computer vision syndrome at 3 and 6 months of follow-up.
Methods Design The research is a doub...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged between 18 and 40 years;
- • 2. In a typical working day, spends at least 2 hours viewing digital devices (e.g., desktop, laptop, tablet, smart phone);
- • 3. Symptoms associated with the use of digital devices, quantified as a score of six points or more on the CVS-Q questionnaire instrument;1
- • 4. Use of spectacles, at least 6, months previous to the beginning of the study;
- • 5. Refractive error between +6.00 to -8.00 with cyl up to 4.00DC.
- Exclusion Criteria:
- • 1. Previous use of accommodative support lenses
- • 2. Ocular pathology requiring referral to an ophthalmologist
- • 3. Wears contact lenses when using computers
- • 4. Strabismus
About The Institute Of Optometry, London
The Institute of Optometry, based in London, is a leading clinical research organization dedicated to advancing the field of optometry through rigorous scientific investigation and innovation. With a focus on enhancing eye health and vision care, the institute conducts a range of clinical trials aimed at developing new treatments and improving patient outcomes. Leveraging a multidisciplinary team of experts and state-of-the-art facilities, the Institute of Optometry is committed to fostering collaboration among researchers, healthcare professionals, and industry partners to drive evidence-based practices in optometry and ophthalmology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alicante, , Spain
London, , United Kingdom
Patients applied
Trial Officials
Bruce Evans, PhD
Study Director
Institute of Optometry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials